Multinational giants pin hopes on wider insurance coverage

Published: 2013-06-28 07:00:00

Updated: 2013-06-28 07:00:00

Riding on the government’s plan to broaden coverage of expenses related to the so-called four major illnesses, which was made public yesterday, multinational drug firms expect that their new anticancer drugs with a high price tag will be more easily covered by national health insurance, with a ho...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK